This is HUGE. A Michigan judge ruled that an injured patient can sue pharma for their injury

https://wwmt.com/news/local/michigan-judge-denies-drug-manufacturers-immunity-in-case-of-contaminated-covid-19-medication

As reported on a local Michigan news station, a man received Remdesivir that was part of a recalled lot of the drug. They determined that a few lots of 55,000 vials contained “glass fragments/particles”. The plaintiff received 5 doses of Remdesivir, and at least 2 of the doses were from the recalled lot with glass particles in it.

“Days later, he suffered a massive stroke and other serious complications. Nowacki developed hematomas and swelling on his face, thighs and arms. According to the lawsuit, around December 16, 2021, Nowacki suffered another stroke, which left him permanently bedridden and in need of 24/7 round-the-clock care.”

Pharma argued that under the PREP act for emergency use, pharma could not be sued for this incident. The Michigan judge saw it a different way. “On July 12, 2023 and August 2, 2023, Judge Carol Kuhnke heard oral arguments from both Ven Johnson Law and the defendants as to whether the case should continue to trial. The defendants in the lawsuit was filed in Washtenaw County Circuit Court and listed Gilead Sciences, Inc., the drug manufacturer and St. Joseph Mercy Chelsea Hospital, Inc. as defendants. The judge ruled that Congress did not plan to extend the PREP Act immunity to a drug that substantially deviated from FDA approval and included glass particles.”

The defendants now must stand trial.